Rhabdomyosarcoma is the most common soft tissue sarcoma in childhood. While based on the cooperative group work from US and Europe diagnosis and treatment guidelines exist management controversies exist for newly diagnosed intermediate and high risk disease and in patients with relapses. The presentation will discuss further details on management of these patient groups in the light of recent published work.

Non-rhabdomyosarcomatous soft tissue sarcomas (NRSTS)

NRSTS are large group of heterogenous group of soft tissue sarcoma diagnoses representing half of all childhood soft tissue sarcomas. In this presentation we will review standard approach in general on diagnosis and management of soft tissue tumors and further discuss how recent molecular work informs diagnosis and management of subgroup of patients.